👀Gali Halevi on assessing attention metrics: "as more open publishing channels & open scholarship data become available, there might be more room to consider them in the future, especially as we seek to understand the overall impact of research.”
🔗https://t.co/TroGf8blIT
We identified countries with the highest potential vulnerability for #COVID19 based on percentage of elderly population and rates of underlying health conditions
#NCDs#NonCommunicableDiseases#noncommunicablediseases
With our European partners, we've worked on the MAPPING_NCD project funded @EU_Commission on the research impact of Europe in outputs, funding, clinical guidelines & health policy. Who's reading this? https://t.co/MBRj3SHKQY
@CLAHRC_NWL @CLAHRC_N_Thames @CLAHRC_SL colleagues - part of the organising committee #NIHRCareers @NIHRAcademy conference - all here & excited to be part of this learning day!
"Remember that the 3 important questions for Scheme award applications is: How do they benefit, why do they benefit and when do they benefit?" Prof David Jones @NIHRAcademy #NIHRCareers @CLAHRC_SL @clahrc_nwc @CLAHRC_N_Thames
Excited to be part of the @CLAHRC_NWL @CLAHRC_SL @CLAHRC_N_Thames #NIHRCareers event tomorrow working along with @LauraLennox3@ElenaPallari and others to make this a great and exciting learning event.
Thank you Chief Medical Officer @CyprusMOH, Health Monitoring Unit, Cyprus Mental Health Commission, Cyprus Medical Association, the Cyprus Monitoring Centre for Drugs and Drug Addiction, the Cyprus Society of Cardiology, CING @lphylactou for your support https://t.co/i2h0AQ0oOZ
The contribution of Cyprus to non-communicable diseases and biomedical research from 2002 to 2013: implications for evidence-based health policy https://t.co/cCPhl8W0hJ